In our previous articles, we reported that the Federal Circuit affirmed the district court’s decision on December 20, 2024 ordering Teva Pharmaceuticals (“Teva”) to delist certain patents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback